Medication info
Cosartan Tablets (Losartan Potassium)

Cosartan Tablets (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Hana Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200703964 · Notified 2007.04.05 · Insurance code 657801890

Summary

Main use
Treatment of nephropathy in patients with hypertension and type 2 diabetes
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that you take it at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the response is inadequate, the same dose may be given orally in 2 divided doses per day, or, if necessary, the dose may be increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be used in combination with other antihypertensive agents (e.g., a low-dose diuretic). An additive effect has been observed when used in combination with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be used in combination with insulin and commonly used blood glucose-lowering agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No initial dose adjustment is necessary for elderly patients up to 75 years of age. For patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with intravascular volume depletion For patients who may have intravascular volume depletion (e.g., patients receiving diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). 4) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents aged 6 years and older, weighing 20 kg or more and less than 50 kg, who can swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years and older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
Hana Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of nephropathy in patients with hypertension and type 2 diabetes

  • Hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used to treat hypertension. It is also helpful in treating kidney disease in patients with type 2 diabetes associated with hypertension. Thus, it contributes to blood pressure control and protection of kidney function, improving the health of patients.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that you take it at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the response is inadequate, the same dose may be given orally in 2 divided doses per day, or, if necessary, the dose may be increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be used in combination with other antihypertensive agents (e.g., a low-dose diuretic). An additive effect has been observed when used in combination with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be used in combination with insulin and commonly used blood glucose-lowering agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No initial dose adjustment is necessary for elderly patients up to 75 years of age. For patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with intravascular volume depletion For patients who may have intravascular volume depletion (e.g., patients receiving diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). 4) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents aged 6 years and older, weighing 20 kg or more and less than 50 kg, who can swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years and older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This medicine can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should not be taken by pregnant women or women who may become pregnant. This medication should not be administered to patients with severely impaired liver function or some genetic lactose intolerance, and caution is required for patients with hyperkalemia or severe renal dysfunction. Caution should be exercised when using this drug in elderly patients, patients with excessively low blood pressure, or those with heart or kidney problems, as there is a risk of a sudden drop in blood pressure, and blood pressure should be monitored frequently. Dizziness or drowsiness may occur while taking this medication, so caution is needed when driving or operating machinery. Taking this medication in conjunction with potassium-sparing diuretics or potassium supplements can lead to dangerously high potassium levels in the blood, so it is best not to combine them. Occasionally, serious allergic reactions such as angioedema, where the face, lips, or tongue swell, can occur, so if these symptoms arise, stop taking the medication immediately and seek medical attention. It is important to regularly check blood pressure, kidney function, and blood potassium levels during treatment to ensure there are no abnormalities. In case of overdose, hypotension and bradycardia may occur, so if symptoms appear, visit a medical facility immediately for appropriate treatment. Women who are pregnant or breastfeeding should avoid taking this medication, and if it is unavoidable, they must consult a doctor. This medication is not administered to children, especially those under 6 years of age or children with severe renal impairment. When storing the medication, keep it out of reach of children and do not transfer it to other containers.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • muscle cramps
  • back pain
  • leg pain
  • dizziness
  • congestion
  • upper respiratory infection
Show 126 more
  • sinusitis
  • nausea
  • diarrhea
  • indigestion
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • distention
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm peeling
  • hemolysis
  • facial swelling
  • fever
  • orthostatic effect
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • joint pain
  • arthritis
  • fibromyalgia
  • muscle weakness
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory reduction
  • decreased libido
  • memory impairment
  • migraine
  • neuroasthenia
  • sensory abnormalities
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnolence
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • nasal bleeding
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitivity reaction
  • pruritus
  • rash
  • sweating
  • urticaria
  • blurred vision
  • eye burning
  • pain
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • vision impairment
  • erectile dysfunction
  • nocturnal enuresis
  • increased urination
  • urethral infection
  • dry cough
  • vascular edema
  • vasculitis
  • anaphylactoid syndrome
  • abnormal liver function
  • hepatitis
  • intestinal vascular edema
  • malaise
  • thrombocytopenia
  • myalgia
  • weakness
  • elevated creatine kinase
  • rhabdomyolysis
  • dysgeusia
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic beats
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering, ideally in a cool, dry place at a temperature between 15 and 30 degrees Celsius.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.